Patent · US Active

OCT4 and SOX2 with SV40 T antigen produce pluripotent stem cells from primate somatic cells

US8268620B2 · kind B2 · utility

25Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2009
Grant dateSep 18, 2012
Priority date
Expiry dateDec 10, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods for reprogramming primate somatic cells to pluripotency using an episomal vector that does not encode an infectious virus are disclosed. Pluripotent cells produced in the methods are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.